0001140361-18-012637.txt : 20180308
0001140361-18-012637.hdr.sgml : 20180308
20180308170435
ACCESSION NUMBER: 0001140361-18-012637
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180306
FILED AS OF DATE: 20180308
DATE AS OF CHANGE: 20180308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paulson John
CENTRAL INDEX KEY: 0001394923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 18677316
MAIL ADDRESS:
STREET 1: 1251 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
doc1.xml
FORM 4
X0306
4
2018-03-06
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001394923
Paulson John
1251 AVENUE OF THE AMERICAS
NEW YORK
NY
10020
1
0
0
0
Common Stock, no par value
2018-03-06
4
S
0
7066629
15.40
D
13772406
I
By Managed Funds
Common Stock, no par value
2018-03-06
4
P
0
7066629
15.40
A
20839035
I
By Managed Funds
John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
Represent rebalancing transactions between the Funds.
/s/ John Paulson
2018-03-08